---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286589455.md"
description: "Artelo Biosciences shares are trading lower after the company reported worse-than-expected Q1 EPS results."
datetime: "2026-05-15T15:16:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286589455.md)
  - [en](https://longbridge.com/en/news/286589455.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286589455.md)
---

# 

Artelo Biosciences shares are trading lower after the company reported worse-than-expected Q1 EPS results.

### Related Stocks

- [ARTL.US](https://longbridge.com/en/quote/ARTL.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)

## Related News & Research

- [Artelo Biosciences Q1 net loss widens, R&D expenses fall](https://longbridge.com/en/news/286462732.md)
- [Kite presents updated Phase 1 data for KITE-753 CAR-T in relapsed B-cell lymphoma](https://longbridge.com/en/news/287273996.md)
- [Lynozyfic® shows quick, significant responses in all second-line-plus systemic AL amyloidosis patients.](https://longbridge.com/en/news/287274655.md)
- [Vertex Says Health Canada Accepts Suzetrigine Application for Review](https://longbridge.com/en/news/287257602.md)
- [Tiziana Announces New Positive Clinical Data For Intranasal Foralumab In Non-Active Secondary Progressive Multiple Sclerosis](https://longbridge.com/en/news/286899753.md)